Review: taking Metoprolol succinate and Tramadol together


Summary

Drug interactions are reported among people who take Metoprolol succinate and Tramadol together. This review analyzes the effectiveness and drug interactions between Metoprolol succinate and Tramadol. It is created by eHealthMe based on reports of 1,859 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol succinate and Tramadol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Succinate

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. (latest outcomes from Metoprolol succinate 18,440 users)

Tramadol

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. (latest outcomes from Tramadol 49,036 users)

On Aug, 19, 2016

1,859 people who take Metoprolol Succinate, Tramadol are studied.


Number of reports submitted per year:

Metoprolol succinate and Tramadol drug interactions.

Drug effectiveness over time:

Metoprolol Succinate:
  • < 1 month: 33.0% - (2 of 6 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 100.0% - (3 of 3 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 57.0% - (4 of 7 people)
  • 5 - 10 years: 44.0% - (4 of 9 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 0 people)
Tramadol:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 25.0% - (1 of 4 people)
  • 1 - 2 years: 22.0% - (2 of 9 people)
  • 2 - 5 years: 36.0% - (4 of 11 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Metoprolol Succinate:
  • female: 59.0% - (13 of 22 people)
  • male: 36.0% - (4 of 11 people)
Tramadol:
  • female: 33.0% - (8 of 24 people)
  • male: 0.0% - (0 of 10 people)

Drug effectiveness by age:

Metoprolol Succinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (2 of 4 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 71.0% - (5 of 7 people)
  • 50-59: 37.0% - (3 of 8 people)
  • 60+: 54.0% - (6 of 11 people)
Tramadol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 4 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 50.0% - (4 of 8 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 18.0% - (2 of 11 people)

Most common drug interactions over time *:

< 1 month:
  • angina pectoris
  • international normalised ratio increased
  • fatigue
  • abscess
  • blood creatinine increased
  • blood pressure increased
  • chest pain
  • exostosis
  • localised infection
  • muscular weakness
1 - 6 months:
  • dyspnoea
  • blood pressure decreased
  • dementia
  • pain
  • arteriosclerosis
  • cardio-respiratory arrest
  • coagulopathy
  • diarrhoea
  • fatigue
  • haemorrhage
6 - 12 months:
  • dizziness
  • depression
  • loss of consciousness
  • pneumonia
  • cerebrovascular accident
  • disorientation
  • fatigue
  • frequent or urgent urination
  • hair loss
  • hypotension
1 - 2 years:
  • arrhythmia
  • cough aggravated
  • renal failure acute
  • acid reflux
  • back pain
  • barrett's esophagus
  • degenerative joint disease
  • dry eyes
  • dvt
  • edema - peripheral, peripheral edema
2 - 5 years:
  • hair loss
  • depression
  • fatigue
  • tachycardia
  • balance disorder
  • frequent or urgent urination
  • increased tendency to bruise
  • lightheadedness
  • menstruation irregular
  • migraine
5 - 10 years:
  • dizziness
  • hypotension
  • loss of consciousness
  • mental status changes
  • abnormal behaviour
  • aggression
  • anxiety
  • arrhythmia
  • cough aggravated
  • disorientation
10+ years:
  • c-reactive protein increased
  • drug rash with eosinophilia and systemic symptoms
  • eosinophilia
  • hepatitis cholestatic
  • diarrhoea
  • gouty arthritis
  • pain in extremity
  • prostatomegaly
  • renal failure acute
not specified:
  • nausea
  • pain
  • dyspnoea
  • fatigue
  • anxiety
  • vomiting
  • back pain
  • diarrhoea
  • hypertension
  • fall

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • dyspnoea
  • anxiety
  • diarrhoea
  • fatigue
  • hypertension
  • fall
  • back pain
  • cardiac failure congestive
male:
  • nausea
  • dyspnoea
  • fatigue
  • vomiting
  • anxiety
  • back pain
  • pain
  • atrial fibrillation
  • depression
  • myocardial infarction

Most common drug interactions by age *:

0-1:
  • bradycardia
  • convulsion
  • syncope
10-19:
  • hip arthroplasty
  • adverse drug reaction
  • amnesia
  • arthralgia
  • arthropathy
  • asthenia
  • brain injury
  • conjunctivitis
  • deep vein thrombosis
  • deformity
20-29:
  • diarrhoea
  • abdominal pain
  • abdominal pain upper
  • nausea
  • vomiting
  • cholecystitis chronic
  • deep vein thrombosis
  • pain
  • pain in extremity
  • abdominal discomfort
30-39:
  • pulmonary embolism
  • deep vein thrombosis
  • diabetes mellitus
  • chest pain
  • nausea
  • pain in extremity
  • muscle spasms
  • type 2 diabetes mellitus
  • anxiety
  • dysphagia
40-49:
  • pain
  • fatigue
  • back pain
  • depression
  • nausea
  • anxiety
  • dyspnoea
  • diarrhoea
  • injury
  • cardiac failure congestive
50-59:
  • nausea
  • pain
  • hypertension
  • anxiety
  • diarrhoea
  • fatigue
  • chest pain
  • cardiac failure congestive
  • cough
  • dyspnoea
60+:
  • nausea
  • dyspnoea
  • vomiting
  • pain
  • asthenia
  • fatigue
  • fall
  • back pain
  • diarrhoea
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol succinate and Tramadol?

Can you answer these questions?

More questions for: Metoprolol succinate, Tramadol

You may be interested in these reviews

More reviews for: Metoprolol succinate, Tramadol

On eHealthMe, Metoprolol succinate (metoprolol succinate) is often used to treat high blood pressure. Tramadol (tramadol hydrochloride) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.